This list is based on the watchlists of people on Stock Events who follow RBSH. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Show more...
FAQ
What is Rebus stock price today?▼
The current price of RBSH is $0 USD — it has increased by +0% in the past 24 hours. Watch Rebus stock price performance more closely on the chart.
What is Rebus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rebus stocks are traded under the ticker RBSH.
What is Rebus market cap?▼
Today Rebus has the market capitalization of 3,213.3
What were Rebus earnings last quarter?▼
RBSH earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rebus revenue for the last year?▼
Rebus revenue for the last year amounts to 0 USD.
What is Rebus net income for the last year?▼
RBSH net income for the last year is -3.09M USD.
How many employees does Rebus have?▼
As of April 03, 2026, the company has 1 employees.
In which sector is Rebus located?▼
Rebus operates in the Health Care sector.
When did Rebus complete a stock split?▼
The last stock split for Rebus was on October 12, 2021 with a ratio of 1:75.
Where is Rebus headquartered?▼
Rebus is headquartered in Westlake Village, US.